Emilse Bermejo
Overview
Explore the profile of Emilse Bermejo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bermejo E, Alberto M, Paul D, Cook A, Nurden P, Luceros A, et al.
Platelets
. 2017 Jul;
29(1):84-86.
PMID: 28726538
Congenital platelet function disorders are often the result of defects in critical signal transduction pathways required for platelet adhesion and clot formation. Mutations affecting RASGRP2, the gene encoding the Rap...
2.
Westbury S, Canault M, Greene D, Bermejo E, Hanlon K, Lambert M, et al.
Blood
. 2017 Jun;
130(8):1026-1030.
PMID: 28637664
Heritable platelet function disorders (PFDs) are genetically heterogeneous and poorly characterized. Pathogenic variants in , which encodes calcium and diacylglycerol-regulated guanine exchange factor I (CalDAG-GEFI), have been reported previously in...
3.
Woods A, Kempfer A, Paiva J, Sanchez-Luceros A, Bermejo E, Chuit R, et al.
Semin Thromb Hemost
. 2016 Dec;
43(1):92-100.
PMID: 27978591
von Willebrand disease type 2B (VWD2B) expresses gain-of-function mutations that enhance binding of an individual's von Willebrand factor (VWF) to its platelet ligand, glycoprotein Ib (GPIb), and which are usually...
4.
Sanchez-Luceros A, Woods A, Bermejo E, Shukla S, Acharya S, Lavin M, et al.
Platelets
. 2016 Nov;
28(5):484-490.
PMID: 27819553
Despite the increased worldwide awareness, over the last decade, of the platelet-type von Willebrand Disease (PT-VWD), many uncertainties remain around this rare platelet bleeding disorder. This report aims to correctly...
5.
Simeoni I, Stephens J, Hu F, Deevi S, Megy K, Bariana T, et al.
Blood
. 2016 Apr;
127(23):2791-803.
PMID: 27084890
Inherited bleeding, thrombotic, and platelet disorders (BPDs) are diseases that affect ∼300 individuals per million births. With the exception of hemophilia and von Willebrand disease patients, a molecular analysis for...
6.
Gagliardi J, Maciel N, Castellano J, Masoli O, Miksztowicz V, Berg G, et al.
Thromb Res
. 2015 Nov;
137:92-96.
PMID: 26577258
Background: The aim of our study was to evaluate the effect of programmed physical activity and a single exercise test on the number of CD309+ circulating endothelial progenitor cell (EPC)...
7.
Woods A, Sanchez-Luceros A, Bermejo E, Paiva J, Alberto M, Grosso S, et al.
Semin Thromb Hemost
. 2014 Jan;
40(2):151-60.
PMID: 24474090
Platelet-type von Willebrand disease (PT-VWD) and type 2B von Willebrand disease (2B-VWD) are rare bleeding disorders characterized by increased ristocetin-induced platelet aggregation (RIPA) at low concentrations of ristocetin. Diagnosis of...
8.
Nurden A, Nurden P, Bermejo E, Combrie R, McVicar D, Washington A
Thromb Haemost
. 2008 Jul;
100(1):45-51.
PMID: 18612537
The Gray platelet syndrome (GPS) is a rare inherited disorder linked to undefined molecular abnormalities that prevent the formation and maturation of alpha-granules. Here, we report studies on two patients...
9.
Bermejo E, Saenz D, Alberto F, Rosenstein R, Bari S, Lazzari M
Thromb Haemost
. 2005 Nov;
94(3):578-84.
PMID: 16268475
There is a growing body of evidence on the role of nitric oxide (NO) in human platelet physiology regulation. Recently, interest has developed in the functional role of an alternative...
10.
Nurden P, Clofent-Sanchez G, Jais C, Bermejo E, Leroux L, Coste P, et al.
Thromb Haemost
. 2004 Oct;
92(4):820-8.
PMID: 15467914
Abciximab is an anti-GPIIb-IIIa drug widely used to prevent thrombotic complications during percutaneous coronary intervention. We now report on the immunologic origin of thrombocytopenia developing between 7 and 12 days...